share_log

Alliance Global Partners Maintains Buy on NeuroOne Medical Tech, Lowers Price Target to $2.2

Alliance Global Partners Maintains Buy on NeuroOne Medical Tech, Lowers Price Target to $2.2

Alliance Global Partners维持买入NeuroOne Medical Tech,将目标
Benzinga ·  2023/08/15 10:51

Alliance Global Partners analyst Ben Haynor maintains NeuroOne Medical Tech (NASDAQ:NMTC) with a Buy and lowers the price target from $3.25 to $2.2.

Alliance Global Partners分析师本·海诺维持NeuroOne Medical Tech(纳斯达克股票代码:NMTC)的买入,并将目标股价从3.25美元下调至2.2美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发